共查询到20条相似文献，搜索用时 953 毫秒
1.
2.
通过等位基因交换,分别敲除牛流产型布鲁菌减毒活疫苗S19株和缺失株S19-Δbp26的znuA基因,构建了布鲁菌znuA基因单缺失株S19-ΔznuA和bp26、znuA基因双缺失株S19-Δbp26-ΔznuA,对获得的2种缺失株进行形态学、生长特性、稳定性和基因测序验证。结果表明,S19株和S19-Δbp26株的znuA基因均成功缺失,生长特性表示2种缺失株与亲本株生长基本无差异;体外连续传至20代,菌落PCR鉴定及基因测序结果显示2种缺失株均遗传稳定。牛流产型布鲁菌单缺失株S19-ΔznuA和双缺失株S19-ΔznuA-Δbp26的成功构建为布鲁菌新型疫苗的研发、布鲁菌感染动物过程中ZnuA蛋白的作用机理及其与Bp26蛋白之间关系的研究奠定了基础。 相似文献
3.
《中国动物传染病学报》2016,(3)
布鲁菌病是由布鲁菌感染引起的呈全球性分布的人畜共患细菌性传染病。布鲁菌是一种兼性胞内菌,感染宿主依赖多种基因的表达和调控。近年来,胞内菌的碳代谢与致病力的关系成为研究的热点。前期研究发现碳代谢相关的丙酮酸磷酸双激酶(ppdk)基因与布鲁菌毒力相关。本研究利用同源重组方法构建流产布鲁菌ppdk基因缺失株,通过环境压力因子耐受性实验、胞内存活实验和动物致病性实验等探讨ppdk基因对布鲁菌毒力的影响。结果显示,ppdk基因缺失能减弱布鲁菌对多粘菌素B和大牛血清的抵抗性,减弱细菌胞内存活的能力和对小鼠的致病力,表明ppdk基因与流产布鲁菌的毒力密切相关。 相似文献
4.
首先采用RT-PCR鉴定布鲁菌16M在模拟胞内条件下BSR1955的转录,利用TargetRNA2预测BSR1955的靶基因;然后采用融合PCR构建BSR1955缺失株;将BSR1955插入pBBR1-MCS4质粒并电转入16M构建过表达株16M-BSR1955;分析缺失株和过表达株在模拟胞内环境和小鼠体内的存活能力。BSR1955在布鲁菌16M中存在转录且在不同刺激条件下转录水平不同;共预测出BSR1955的靶基因45个;BSR1955缺失或过表达影响布鲁菌16M在体外的生长能力,缺失BSR1955后在高盐、高渗环境中生存能力提高,第28和45天在小鼠脾脏内的细菌数量显著增加,表明BSR1955影响了布鲁菌的毒力。非编码小RNABSR1955影响布鲁菌16M在胞内的生存能力。 相似文献
5.
利用λ-Red同源重组技术构建鼠伤寒沙门菌oppCDF基因缺失株,并检测其生长特性、运动性、生物被膜形成能力、胞内存活能力及LD50毒力。结果显示,与野生型菌株相比,oppCDF基因缺失株的生长特性无明显变化;oppCDF基因缺失株可降低鼠伤寒沙门菌的运动性;oppC与oppF基因缺失后可提高鼠伤寒沙门菌生物被膜形成能力;同时,oppC基因缺失可降低在RAW267.4细胞内的存活能力和其在小鼠体内的毒力,oppF基因缺失可显著增强在RAW267.4内的存活能力和对小鼠毒力的影响,而oppD基因缺失后其在小鼠体内的毒力和RAW267.4内的存活率均无显著变化。研究表明,oppCDF基因与鼠伤寒沙门菌的运动性、生物被膜形成和毒力密切相关,为进一步揭示鼠伤寒沙门菌致病作用中的复杂调控和机制提供了理论基础。 相似文献
6.
《中国兽医学报》2015,(8):1275-1279
为了探讨crp、cya、sipB、crp/cya、crp/sipB基因缺失株成为鼠伤寒沙门菌减毒候选活疫苗的可能性,对缺失株的生物学特性进行研究。结果显示,缺失株的血清型仍和亲本菌株相同,其中crp、cya、crp/cya、crp/sipB与亲本菌株相比失去了利用麦芽糖、乳糖、山梨醇等碳源的能力,也不能分解H2S、半乳糖和鼠李糖,但仍保留了利用葡萄糖的能力。通过口服方式把5株crp、cya、sipB、crp/cya、crp/sipB基因缺失株接种KM小鼠进行毒力测定和免疫保护性测定,结果它们的半数致死量比野生株的至少高700倍,双基因缺失株的毒力更弱,攻毒后crp、cya、sipB、crp/cya、crp/sipB基因缺失株的免疫保护率分别为90.0%,60.0%,50.0%,60.0%,60.0%。结果表明,crp基因缺失株可作为鼠伤寒沙门菌减毒活疫苗的候选株。 相似文献
7.
《中国预防兽医学报》2016,(1)
为分析二元调控系统TcfSR在布鲁菌胞内存活中的调控作用,本研究采用同源重组和抗性替换的方法,利用卡那基因替换TcfSR启动子,构建布鲁菌16M株的突变株16MΔTcfSR,并利用亲本株和突变株侵染小鼠巨噬细胞,比较两者在宿主细胞内的生存能力及其胞内存活相关毒力基因的转录情况。同时在各种逆环境下刺激亲本株和突变株,比较两者在逆环境中的存活能力。结果显示16MΔTcf SR在小鼠巨噬细胞和逆环境中的存活能力均比亲本株下降,并且突变株的胞内存活相关毒力基因的转录水平较亲本株具有差异。表明TcfSR在布鲁菌胞内存活过程中具有重要的调控作用。本研究初步阐明了TCRS Tcf SR的调控机制,为进一步研究TCRS在布鲁菌致病过程中的作用奠定了基础。 相似文献
8.
兔支气管败血波氏杆菌PRN基因缺失突变株的构建及特性研究 总被引：1，自引：1，他引：0
利用自杀性质粒构建兔支气管败血波氏杆菌百日咳黏附素(PRN)缺失突变株以研究PRN在支气管败血波氏杆菌(Bb)致病机理中的作用,同时为支气管败血波氏杆菌病减毒活疫苗的研究提供理论依据.PCR扩增出PRN1(PRN上游基因)和PRN2(PRN下游基因)2个目的基因片段,运用基因重组技术将庆大霉素抗性基因(GM)连接到PRN1和PRN2之间,将连接好的基因片段克隆到pMEG-375自杀性载体中,构建自杀性载体pMEG375-PRN1-GM-PRN2,将其转化到宿主菌SM-10中,通过宿主菌SM-10与受体菌Bb固相滤膜交配,自杀性载体转移到受体菌,根据同源重组原理,抗性筛选得到基因缺失突变株,命名为Bb(△PRN).对突变株Bb(△PRN)与野生株WT进行了遗传稳定性、生长特性、溶血特性、细胞黏附特性、毒力、免疫保护性等比较研究.结果表明:Bb(△PRN)具有遗传稳定性;与野生株相比,突变株生长速度较慢,毒力有所下降,溶血活性及对Hep-2细胞的黏附能力没有明显变化;小鼠免疫原性试验结果显示,突变株免疫小鼠后可以产生强有力的免疫力,能够抵抗野生株的攻击.Bb(△PRN)突变株构建成功并具有良好的免疫原性,为支气管败血波氏杆菌病减毒活疫苗的研究奠定了基础. 相似文献
9.
根据Gen Ban K中发表的多杀性巴氏杆菌(Pasteurella multocida,P.multocida)HN06株(登录号为NC017027)的omp H核苷酸序列设计合成一对特异性引物,将PCR扩增获得的牦牛源P.multocida C47-8的omp H基因片段连接到p MR10载体上,构建了C47-8株Δomp H缺失株互补质粒p MR10-Δomp H,并将该质粒电转化至C47-8Δomp H缺失株中,成功获得其互补菌株。在此基础上,对C47-8亲本株、Δomp H缺失株以及互补株的生物学特性进行研究。形态学观察结果表明,3株菌的生长形态无差异;生化试验结果表明,除了缺失株发酵蕈糖、硝酸盐试验呈现阳性外,3株菌的其余生化特性未发生改变;体外生长曲线表明亲本株C47-8的生长速度比缺失株和互补株的生长速度慢,说明omp H基因对C47-8的生长有显著影响。本试验为深入研究P.multocida的致病机制以及研制安全有效的基因缺失减毒活疫苗奠定了基础。 相似文献
10.
《中国兽医学报》2016,(12):2086-2089
为了解羊种布鲁菌内蒙古分离株和疫苗株的遗传变异情况,对羊种布鲁菌分离株B1、B2、B3、B4以及疫苗株M5、S2、A19的bp26及omp10基因进行了扩增、克隆和序列分析,并与国内外的代表性毒株进行了序列比对。结果显示:4株分离株的bp26序列长度均为900bp,开放阅读框为753bp,与疫苗株M5同源性为100%,疫苗株S2和A19的同源性为99.99%;分析发现所有序列中共有4处变异,A19 bp26基因的CDS区第304位A→G和第405位C→T突变,S2 bp26基因的第498位C→T和727位G→A突变;其中304位的A→G的变异导致其编码的氨基酸发生了从天冬酰胺(N)到天冬氨酸(D),727位G→A的变异导致氨基酸发生了缬氨酸(V)到异亮氨酸(I)的变化;而分离株和疫苗株M5未发生变异。4株分离株的omp10序列长度均为513bp,开放阅读框为396bp,同源性为99.99%,与疫苗株S2和A19同源性为100%;分析发现疫苗株M5的omp10基因序列发生了1处变异,第144位C→T,但没有引起氨基酸改变,其他菌株没有发生变异。 相似文献
11.
12.
布氏杆菌为世界性具重要公共卫生意义的人兽共患疫病原，分6个种。建立种间及种株间安全敏感、经济有效的快速鉴别诊断方法对布病防制及分子流行病学研究具有重要意义。布氏杆菌IS711和omp2基因具有种属特异性，可用于布氏杆菌的PCR分子诊断。其中IS711为转座因子，在不同种布菌种存在插入位置的多态性，外膜蛋白OMP2编码基因则存在反向重复序列及种株间的多态性。为此，分别采用复式-PCR、PCR和限制性酶切片段长多态性（RFLP）分析，对分属于B．mclitcnsis、B．suis和B．abortus的不同种布氏杆菌的不同种株，M5、M16、S2、S6和S19进行分子鉴别诊断。结果显示，根据IS711基因特定PCR扩增片段长多态性，可进行布氏杆菌种间的快速鉴别；而omp2编码基因PCR扩增片段PsrⅠ、KpnⅠ、NcoⅠ和Eco47 Ⅲ等4种限制酶片段长多态性，则可成为布氏杆菌菌株间特异的分子鉴别诊断标记，甚至疫苗株M5和野毒株M16之间的分子诊断标记。 相似文献
13.
Ferrão-Beck L Cardoso R Muñoz PM de Miguel MJ Albert D Ferreira AC Marín CM Thiébaud M Jacques I Grayon M Zygmunt MS Garin-Bastuji B Blasco JM Sá MI 《Veterinary microbiology》2006,115(1-3):269-277
Swine brucellosis is caused by the biovars 1, 2 and 3 of Brucella suis the identification of which up to now relies on microbiological tests lacking adequate specificity together with time consuming and expensive molecular procedures. Based on sequence variation of the omp2b gene, we have developed a four primer set multiplex PCR assay that was tested for polymorphism analysis of B. suis biovars causing brucellosis in swine. The assay exploits the single nucleotide polymorphisms found in omp2b gene of B. suis reference biovars which are conserved in 43 B. suis field isolates from different geographic origins and hosts. Three specific amplification patterns (S1, S2 and S3) were obtained for reference strains of B. suis biovars 1, 2 and 3, respectively. However, some B. suis field isolates identified as biovars 2 or 3 according AMOS-PCR, PCR-RFLP of omp31 and omp2 genes and classical bacteriological methods, resulted also in S1 patterns, limiting the typing usefulness of the method. 相似文献
14.
Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. 总被引：6，自引：3，他引：3 
下载免费PDF全文
下载免费PDF全文 Streptococcus suis capsular type 2 is still an important cause of economic losses in the swine industry. At the present time, vaccination of pigs against this infection is generally carried out with autogenous bacterins and results are equivocal. In this study, the protective effect of a live avirulent S. suis type 2 strain (#1330) which had induced a good protection in mice, was evaluated in swine. The experiment was performed in triplicate using 4 week-old piglets. A total of 15 piglets were vaccinated 3 times, 15 others were vaccinated 2 times, and 15 piglets were injected 3 times with sterile Todd-Hewitt broth. Using an indirect ELISA, an increase in the IgG response to S. suis antigens was noted in 27 of the 30 vaccinated piglets. On day 21 post-vaccination, all animals were challenged intravenously with a virulent S. suis type 2 strain (#999). In the 2 vaccinated groups, 26 animals were fully protected. Only 1 out of the 15 piglets vaccinated 3 times developed mild clinical signs. In the group vaccinated twice, 3 piglets showed clinical signs and 1 of them died after the challenge. In the control group, 7 animals died out of the 11 with clinical signs of infection. In conclusion, a protective immunity was observed in swine when using strain 1330. However, more studies are needed to assess the use of a live S. suis strain in a vaccine for pigs. 相似文献
15.
通过PCR克隆出IBDV VP2基因,将其插入到表达载体pYA3341中,构建重组质粒pYA3341-VP2。将重组质粒电转入鼠伤寒沙门菌疫苗株X4550（缺失Asd、Cya、Crp基因）,获得重组疫苗菌株X4550（pYA3341-VP2）。进行重组菌VP2蛋白表达的鉴定;测定重组菌的稳定性、生长曲线、安全性以及小鼠免疫试验。结果表明,酶切鉴定证实重组质粒构建成功;SDS-PAGE和Western blot证实重组菌表达的VP2蛋白能与鸡抗IBDV阳性血清特异性结合;重组菌株在体外营养选择压力下,可稳定地携带重组质粒传代繁殖,在体内可稳定地定居于肠系膜淋巴结和脾脏;小鼠口服试验证实重组菌无毒性作用;口服重组菌免疫小鼠,ELISA检测产生了抗IBDV抗体;中和试验表明产生的抗体具有中和活性。本试验成功构建了能稳定表达IBDV VP2蛋白的口服减毒鼠伤寒沙门菌疫苗株X4550（pYA3341-VP2）,为研究IBD口服基因工程疫苗奠定了基础。 相似文献
16.
Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection 总被引：7，自引：0，他引：7
Thanawongnuwech R Brown GB Halbur PG Roth JA Royer RL Thacker BJ 《Veterinary pathology》2000,37(2):143-152
Eighty 3-week-old crossbred pigs were randomly assigned to six groups (13-14 pigs/group). Group 1 pigs served as uninoculated controls, group 2 pigs were inoculated intranasally (i.n.) with Streptococcus suis serotype 2, group 3 pigs were inoculated i.n. with a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine, group 4 pigs were inoculated i.n. with the same vaccine and with S. suis, group 5 pigs were inoculated i.n. with VR-2385 (a high-virulence strain of PRRSV), and group 6 pigs were inoculated i.n. with VR-2385 and S. suis. Pigs exposed to both PRRSV and S. suis were inoculated with PRRSV 7 days prior to S. suis inoculation. The pigs were 26 days old when inoculated with S. suis. Respiratory disease was significantly more severe in groups 5 and 6. Mortality rate was the highest in group 6 (87.5%). This rate was significantly higher than that observed in all other groups except group 4 (37.5%). The mortality rate in group 2, inoculated with S. suis alone, was 14.3%. No pigs from groups 1, 3, or 5 died prior to the scheduled necropsies at 10 and 28 days postinoculation with PRRSV (DPI). To study the effect of PRRSV and/or S. suis on pulmonary clearance by pulmonary intravascular macrophages, six pigs from each group were intravenously infused with 3% copper phthalocyanine tetrasulfonic acid in saline prior to necropsy at 10 DPI. Mean copper levels in the lungs of pigs in groups 2, 5, and 6 were significantly lower than those in control pigs. The mean percentage of lung tissue grossly affected by pneumonia at 10 DPI was 0%, 1%, 0%, 3%, 64%, and 62% for groups 1-6, respectively. Both gross and microscopic interstitial pneumonia lesions were significantly more severe in the VR2385-inoculated groups (5 and 6). PRRSV was isolated from bronchoalveolar lavage fluid collected at necropsy from 100% of the pigs in groups 5 and 6, 71.4% of pigs in group 4, 38.5% of pigs in group 3, and none of the pigs in groups 1 or 2. Streptococcus suis serotype 2 was cultured from the internal tissues of 7.7%, 28.6%, and 78.6% of the pigs in groups 2, 4, and 6, respectively. Streptococcus suis serotype 2 was isolated from whole blood at necropsy from 7.7%, 35.7%, and 78.6% of pigs in groups 2, 4, and 6, respectively. Significantly more pigs in group 6 had S. suis isolated from whole blood and internal tissues. In summary, both high-virulence PRRSV and S. suis decreased copper clearance, and the incidence of isolation of S. suis and PRRSV was higher in dually inoculated pigs. PRRSV-induced suppression of pulmonary intravascular macrophage function may in part explain PRRSV-associated increased susceptibility to S. suis infection. 相似文献
17.
Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2. 总被引：4，自引：0，他引：4
Henk J Wisselink Norbert Stockhofe-Zurwieden Luuk A T Hilgers Hilde E Smith 《Veterinary microbiology》2002,84(1-2):155-168
The protective efficacy of a live and killed non-encapsulated isogenic mutant of Streptococcus suis serotype 2 was determined in pigs, and compared with the efficacy of the capsulated wild-type strain. SPF pigs were vaccinated twice intramuscularly at 4 and 7 weeks of age with a dose of 1 x 10(9) formalin-killed CFU of the wild-type (WT-BAC), formalin-killed non-encapsulated mutant (CM-BAC) or live non-encapsulated mutant (CM-LIVE) strain. After 2 weeks, vaccinated pigs and non-vaccinated controls were challenged intravenously with 1 x 10(7) CFU of the homologous, wild-type S. suis serotype 2 strain. Protection was evaluated by clinical, bacteriological, serological and post-mortem examinations. All pigs vaccinated with WT-BAC were completely protected against challenge with the homologous serotype. Pigs vaccinated with CM-BAC were partially protected. Although all pigs vaccinated with CM-BAC survived the challenge, four out of five pigs developed clinical signs of disease for several days. Compared to the WT-BAC and CM-BAC, the CM-LIVE vaccine was less protective. Two out of five pigs vaccinated with CM-LIVE died in the course of the experiment and all of them developed specific clinical signs of disease for several days. The protective efficacy of the vaccines could be associated with serum antibody titers. Antibody titers against cells of wild-type and non-encapsulated mutant strains as well as against muramidase-released proteins (MRP) were high in pigs vaccinated with WT-BAC and CM-BAC. Pigs vaccinated with CM-LIVE showed lower antibody titers. Antibody titers against purified capsular polysaccharides (CPS) of S. suis serotype 2 were only found in pigs vaccinated with WT-BAC. These findings indicate that CPS and other bacterial components of WT-BAC are probably essential for full protection against homologous challenge. 相似文献
18.
为优化猪种布氏杆菌WboA基因缺失株(B.suisΔWboA)对绵羊的免疫条件,本研究采用1岁左右的成年雌性绵羊对B.suisΔWboA的免疫剂量及免程序进行了比较研究。实验分5个组进行,其中A、B、C 3个试验组分别以2倍剂量重复接种、4倍剂量重复接种和单剂量1次接种B.suisΔWboA,D组单剂量1次接种猪种布氏杆菌S2疫苗株(B.suis S2),E组为空白对照组。各组羊首免后7 d、21 d和35 d分别采血,测定血清抗体水平;在首免后35 d,分别采用布氏杆菌强毒菌M28株(B.melitensis M28),经腹股沟皮下注射攻毒。攻毒后28 d,分别取试验羊的脾脏分离攻毒菌株。所有试验羊,在实施攻毒前,其精神、食欲均正常。血清抗体测定结果表明,在二免7 d、21 d后,A组和B组试验羊的抗体水平明显高于C组,而且均超过D组试验羊的抗体水平。攻毒后的细菌分离结果表明,攻毒后28 d,A组和B组试验羊的脾脏细菌分离数量明显低于C组试验羊,并且均低于D组试验羊的细菌分离水平。实验结果表明,B.suisΔWboA的免疫剂量由单倍改为2倍或4倍,免疫程序由单剂量1次改为2倍或4倍剂量2次,可以明显提高免疫效果,并达到与亲本疫苗菌株B.suis S2的免疫水平。 相似文献
19.
为建立区分猪种布鲁菌S2疫苗株接种奶牛与布鲁菌自然感染奶牛,BLAST比对分析羊种、牛种、猪种、犬种、沙林鼠种和绵羊种6种布鲁菌基因序列,发现repA—related基因是猪种布鲁菌与牛种及羊种布鲁菌的差异基因。设计引物PCR扩增获得repA-related基因片段,克隆并原核表达得到了布鲁菌repA—related融合蛋白,以repArelated蛋白建立间接EI．IsA检测方法。用repA—related蛋白间接ELISA检测猪种s2疫苗株接种动物血清为阳性,检测牛种和羊种布鲁菌自然感染动物血清为阴性。repA—related蛋白间接EusA能从试管凝聚实验（SAT）及常规ELIsA检测阳性的奶牛血清样本中,区分出s2疫苗接种牛与牛种布鲁菌感染牛。 相似文献
20.
某地区猪繁殖与呼吸综合征病毒(PRRSV)与中国高致病性猪繁殖与呼吸综合征病毒(hp-PRRSV)同源性极高,为了筛选适合该地区病情的疫苗,指导养殖户生产,试验选择hp-PRRS弱毒活疫苗(JXA1-R株)和PRRS弱毒活疫苗(VR-2332株)作为疫苗候选株,选取30日龄、健康状况良好、群体差异性小的断奶仔猪30头,随机分成A、B和C组,每组10头,A组注射hp-PRRS弱毒活疫苗(JXA1-R株),B组注射PRRS弱毒活疫苗(VR-2332株),C组注射相同剂量生理盐水作对照,免疫前和免疫后14、28、42、56、70、84 d采集血清,通过淋巴细胞计数、血清病毒核酸检测、血清抗体检测等分析猪体内hp-PRRS弱毒活疫苗(JXA1-R株)和PRRS弱毒活疫苗(VR-2332株)免疫应答情况.试验结果显示,淋巴细胞数量方面,仔猪免疫后,淋巴细胞数量均上升,42 d时A、B组均达到最大值,A组为19.3×109/L,B组为16.7×109/L,C组则一直处于原始水平;抗体阳性方面,14 d时A组为80%,B组为60%,C组为0,42 d时A组为100%,B组为80%,C组为0;病毒核酸阳性率方面,14 d时A组为90%,B组为100%,C组为0,42 d时,A组为40%,B组为70%,C组为0,70 d时,A组为0,B组为20%,C组为0.由此可知,hp-PRRS弱毒活疫苗(JXA1-R株)能快速诱导猪发生免疫应答、产生免疫抗体,抗体持续时间长、效价高、稳定性良好,且疫苗毒在体内存在时间短、减毒时间快、安全性高,对所研究地区猪群免疫具有优越效果. 相似文献